Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Sale |
2025-04-08 4:45 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $12.3 | $615,075 | 285,963 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 5:12 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $11.21 | $560,446 | 408,074 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 4:35 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $12.31 | $615,565 | 334,410 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-07 6:24 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $11.1 | $555,065 | 219,410 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:40 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
200,000 | $13.44 | $2,688,751 | 368,852 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 8:04 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $7.7052 | $770,520 | 265,581 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 5:05 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
45,004 | $7.0325 | $316,489 | 235,237 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 6:03 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
54,996 | $7.1249 | $391,841 | 342,629 (Direct) |
View |
| 2023-07-07 Sale |
2023-07-07 8:16 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
8,858 | $6.364 | $56,372 | 313,343 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 8:55 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
91,142 | $6.4784 | $590,453 | 644,043 (Direct) |
View |
| 2023-06-01 Sale |
2023-06-02 7:48 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $6.8404 | $684,041 | 643,281 (Direct) |
View |
| 2022-11-09 Sale |
2023-05-10 4:53 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
143,896 | $5.4246 | $780,579 | 859,240 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Exercise |
2025-04-08 4:45 pm |
N/A 2032-01-31 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $0 | 285,963 (Direct) |
View |
| 2025-04-07 Exercise |
2025-04-08 4:45 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $4.85 | 285,963 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:12 pm |
N/A 2032-01-31 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 408,074 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:12 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $4.85 | 408,074 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
9,064 | $3.15 | 334,410 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A 2032-05-01 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 334,410 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
40,936 | $4.85 | 334,410 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-07 6:24 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $3.15 | 219,410 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-07 6:24 pm |
N/A 2032-05-01 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 219,410 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
77,150 | $3.15 | 368,852 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
122,850 | $1.27 | 368,852 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
200,000 | $0 | 368,852 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 8:05 pm |
N/A 2034-06-02 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
102,225 | $0 | 102,225 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-05 8:04 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $1.27 | 265,581 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-05 8:04 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $0 | 265,581 (Direct) |
View |
| 2023-08-03 Exercise |
2023-08-07 5:05 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
45,004 | $1.27 | 235,237 (Direct) |
View |
| 2023-08-03 Exercise |
2023-08-07 5:05 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
44,914 | $0 | 235,237 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 6:03 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
54,996 | $1.27 | 342,629 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 6:03 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
54,996 | $0 | 342,629 (Direct) |
View |
| 2023-07-07 Exercise |
2023-07-07 8:16 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
8,858 | $1.27 | 313,343 (Direct) |
View |
| 2023-07-07 Exercise |
2023-07-07 8:16 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
8,858 | $0 | 313,343 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:55 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
91,142 | $1.27 | 644,043 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:55 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
91,142 | $0 | 644,043 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-28 9:00 pm |
N/A 2033-06-26 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-02 7:48 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $1.27 | 643,281 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-02 7:48 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $0 | 643,281 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-01 6:31 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
66,055 | $0 | 66,055 (Direct) |
View |
| 2023-05-24 Gift |
2023-05-26 4:14 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
12,099 | $0 | 40,000 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 4:53 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $1.27 | 859,240 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 4:53 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
100,000 | $0 | 859,240 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:38 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
78,740 | $1.27 | 657,239 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:38 pm |
N/A 2030-04-28 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
78,740 | $0 | 657,239 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Nkarta Inc. | NKTX | Shawver Laura Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-05-27 Option Award |
2022-05-27 5:35 pm |
N/A 2032-05-26 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
41,597 | $0 | 41,597 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:19 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
204,321 | $0 | 311,716 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:17 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
297,000 | $0 | 376,895 (Direct) |
View |
| 2021-06-13 Option Award |
2021-06-15 10:25 am |
N/A 2031-06-12 |
Nkarta Inc. | NKTX | Shawver Laura Director |
16,511 | $0 | 16,511 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:46 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:59 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
562,631 | $0 | 562,631 (Direct) |
View |
Ownership |
2020-12-03 8:52 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
0 | $0 | 1,002,995 (Direct) |
View |
Ownership |
2020-07-15 8:18 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
0 | $0 | 73,219 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 9:45 pm |
N/A 2030-07-08 |
Nkarta Inc. | NKTX | Shawver Laura Director |
29,000 | $0 | 29,000 (Direct) |
View |
Ownership |
2020-07-09 8:50 pm |
N/A 2030-03-26 |
Nkarta Inc. | NKTX | Shawver Laura Director |
0 | $0 | 29,729 (Direct) |
View |